Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline - Archive ouverte HAL Access content directly
Journal Articles Nature Communications Year : 2014

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline

Pierre Lechat
  • Function : Author
  • PersonId : 946513
Ivan Moszer
  • Function : Author
  • PersonId : 965953

Abstract

Streptococcus agalactiae (Group B Streptococcus, GBS) is a commensal of the digestive and genitourinary tracts of humans that emerged as the leading cause of bacterial neonatal infections in Europe and North America during the 1960s. Due to the lack of epidemiological and genomic data, the reasons for this emergence are unknown. Here we show by comparative genome analysis and phylogenetic reconstruction of 229 isolates that the rise of human GBS infections corresponds to the selection and worldwide dissemination of only a few clones. The parallel expansion of the clones is preceded by the insertion of integrative and conjugative elements conferring tetracycline resistance (TcR). Thus, we propose that the use of ​tetracycline from 1948 onwards led in humans to the complete replacement of a diverse GBS population by only few TcR clones particularly well adapted to their host, causing the observed emergence of GBS diseases in neonates.
Fichier principal
Vignette du fichier
ncomms5544.pdf (1.11 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-01299769 , version 1 (08-04-2016)

Licence

Attribution - NonCommercial - ShareAlike - CC BY 4.0

Identifiers

Cite

Violette da Cunha, Mark R. Davies, Pierre-Emmanuel Douarre, Isabelle Rosinski-Chupin, Immaculada Margarit, et al.. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline . Nature Communications, 2014, 5, pp.Article 4544. ⟨10.1038/ncomms5544⟩. ⟨pasteur-01299769⟩
1120 View
201 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More